LOGAN CAPITAL MANAGEMENT INC
Position in JAZZ — Jazz Pharmaceuticals plc
CIK 1121330
Newtown Square, PA
Position in JAZZ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$621,702
+$621,702 QoQ
Shares Held
2,580
Ownership
0.004%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#366
of 640 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JAZZ Over Time
Shares Held
Position Value (USD)
Derivatives in JAZZ
reported options exposure · as of Mar 31, 2026CallValue
$0
CallShares
0
PutValue
$485,480
PutShares
2,568
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026LOGAN CAPITAL MANAGEMENT INC holds $622,695 across 2 Biotechnology names. JAZZ ranks #1 (99.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
This page
|
2,580 | $621,702 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2 | $993 |
All Filings in JAZZ
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $621,702 | 2,580 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $485,480 | 2,568 | Put | Sole | 2026-05-08 | |
| 2025-12-31 | $436,560 | 2,568 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $338,462 | 2,568 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $116,095 | 1,094 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $333,715 | 2,688 | Shares | Sole | 2025-05-16 | |
| 2024-12-31 | $339,401 | 2,756 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $438,843 | 3,939 | Shares | Sole | 2024-12-06 | |
| 2024-06-30 | $422,117 | 3,955 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $472,528 | 3,924 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $480,192 | 3,904 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $482,034 | 3,724 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $457,573 | 3,691 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $540,104 | 3,691 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $623,857 | 3,916 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $540,757 | 4,057 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $632,932 | 4,057 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $671,249 | 4,312 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $189,571 | 1,488 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $540,631 | 4,152 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $617,121 | 3,474 | Shares | Sole | 2021-08-17 | |
| 2021-03-31 | $147,439 | 897 | Shares | Sole | 2021-05-14 | |
| No filing history on record for this holder in this stock. | ||||||